Cellexcel secures investment from Anglia Capital Group and New Anglia Capital
The funding will support the commercialisation of proprietary technology that enhances the water resistance of plant-based biomaterials.
Share allotment filed at Companies House
Cellexcel develops chemical modification technology that improves the water resistance of plant-based biomaterials. Its process enables manufacturers to use sustainable composites in high-performance external applications.
Norwich-based Cellexcel has secured investment from Anglia Capital Group and the New Anglia Capital fund, alongside grant backing from Innovate UK. The company has developed proprietary technology designed to prevent plant-based biomaterials from absorbing moisture, allowing them to be deployed in structural applications traditionally reliant on carbon-intensive materials such as fibreglass and metal. The capital will support further technological progress and commercial exploitation across sectors including automotive and aerospace.
Cellexcel originated from research conducted at the University of East Anglia and Norwich Research Park. Its treatment aims to broaden the use of carbon-capturing materials in manufacturing, helping industries reduce both operational and embedded emissions.
From the founder
"The technology developed by Cellexcel will have a significant impact on reducing CO2 emissions as it opens the doorway for a rapid expansion of carbon capturing biomaterials."
Tim Pryce
Chairperson at Cellexcel
Investor perspective
"The innovative technology solutions coming out of the UEA and Norwich Research Park is something that our region can be truly proud of"
Hannah Smith
Managing Director, Anglia Capital Group